These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 39077134)

  • 1. Unsolved Questions in the Revascularization of Older Myocardial Infarction Patients with Multivessel Disease.
    Pavasini R; Sanguettoli F; Zanarelli L; Deserio MA; Bianchi N; Fabbri G; Tebaldi M; Biscaglia S; Campo G
    Rev Cardiovasc Med; 2022 Oct; 23(10):344. PubMed ID: 39077134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Balancing benefit against risk in the choice of therapy for coronary artery disease. Lesson from prospective, randomized, clinical trials of percutaneous coronary intervention and coronary artery bypass graft surgery.
    Morrison DA; Sacks J
    Minerva Cardioangiol; 2003 Oct; 51(5):585-97. PubMed ID: 14551526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete Revascularization by Percutaneous Coronary Intervention for Patients With ST-Segment-Elevation Myocardial Infarction and Multivessel Coronary Artery Disease: An Updated Meta-Analysis of Randomized Trials.
    Ahmad Y; Howard JP; Arnold A; Prasad M; Seligman H; Cook CM; Warisawa T; Shun-Shun M; Ali Z; Parikh MA; Al-Lamee R; Sen S; Francis D; Moses JW; Leon MB; Stone GW; Karmpaliotis D
    J Am Heart Assoc; 2020 Jun; 9(12):e015263. PubMed ID: 32476540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Updated Strategies in Non-Culprit Stenosis Management of Multivessel Coronary Disease-A Contemporary Review.
    Manuca RD; Covic AM; Brinza C; Floria M; Statescu C; Covic A; Burlacu A
    Medicina (Kaunas); 2024 Feb; 60(2):. PubMed ID: 38399550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multivessel Versus Culprit-Only Revascularization in STEMI and Multivessel Coronary Artery Disease: Meta-Analysis of Randomized Trials.
    Atti V; Gwon Y; Narayanan MA; Garcia S; Sandoval Y; Brilakis ES; Basir MB; Turagam MK; Khandelwal A; Mena-Hurtado C; Mamas MA; Abbott JD; Bhatt DL; Velagapudi P
    JACC Cardiovasc Interv; 2020 Jul; 13(13):1571-1582. PubMed ID: 32646699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staged complete revascularization or culprit-only percutaneous coronary intervention for multivessel coronary artery disease in patients with ST-segment elevation myocardial infarction and diabetes.
    Cui K; Lyu S; Liu H; Song X; Yuan F; Xu F; Zhang M; Wang W; Zhang M; Zhang D; Tian J
    Cardiovasc Diabetol; 2019 Sep; 18(1):119. PubMed ID: 31530274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Percutaneous Coronary Intervention on Death and Myocardial Infarction Stratified by Stable and Unstable Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials.
    Chacko L; P Howard J; Rajkumar C; Nowbar AN; Kane C; Mahdi D; Foley M; Shun-Shin M; Cole G; Sen S; Al-Lamee R; Francis DP; Ahmad Y
    Circ Cardiovasc Qual Outcomes; 2020 Feb; 13(2):e006363. PubMed ID: 32063040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-Analysis of Complete versus Culprit-Only Revascularization in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Disease.
    Levett JY; Windle SB; Filion KB; Cabaussel J; Eisenberg MJ
    Am J Cardiol; 2020 Nov; 135():40-49. PubMed ID: 32871112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immediate Versus Staged Multivessel PCI Strategies in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A Systematic Review and Meta-Analysis.
    Hu MJ; Yang YJ; Yang JG
    Am J Med Sci; 2022 Feb; 363(2):161-173. PubMed ID: 34274323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is optimal revascularization strategy in patients with multivessel coronary artery disease in non-ST-elevation myocardial infarction? Multivessel or culprit-only revascularization.
    Kim MC; Jeong MH; Ahn Y; Kim JH; Chae SC; Kim YJ; Hur SH; Seong IW; Hong TJ; Choi DH; Cho MC; Kim CJ; Seung KB; Chung WS; Jang YS; Cho SY; Rha SW; Bae JH; Cho JG; Park SJ;
    Int J Cardiol; 2011 Dec; 153(2):148-53. PubMed ID: 20843572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Culprit-Only Revascularization, Single-Setting Complete Revascularization, and Staged Complete Revascularization in Acute Myocardial Infarction: Insights From a Mixed Treatment Comparison Meta-Analysis of Randomized Trials.
    Maqsood MH; Tamis-Holland JE; Rao SV; Stone GW; Bangalore S
    Circ Cardiovasc Interv; 2024 Jul; 17(7):e013737. PubMed ID: 38973504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete Revascularization During Primary Percutaneous Coronary Intervention Reduces Death and Myocardial Infarction in Patients With Multivessel Disease: Meta-Analysis and Meta-Regression of Randomized Trials.
    Pasceri V; Patti G; Pelliccia F; Gaudio C; Speciale G; Mehran R; Dangas GD
    JACC Cardiovasc Interv; 2018 May; 11(9):833-843. PubMed ID: 29747913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of multivessel coronary artery revascularization versus culprit-only revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease.
    Bangalore S; Kumar S; Poddar KL; Ramasamy S; Rha SW; Faxon DP
    Am J Cardiol; 2011 May; 107(9):1300-10. PubMed ID: 21349487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of acute coronary syndromes in patients with diabetes: implications of the FREEDOM trial.
    Burgess SN; Mussap CJ; French JK
    Clin Ther; 2013 Aug; 35(8):1069-75. PubMed ID: 23973040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-Analysis of Culprit-Only Versus Multivessel Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Disease.
    Bangalore S; Toklu B; Stone GW
    Am J Cardiol; 2018 Mar; 121(5):529-536. PubMed ID: 29304995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of fractional flow reserve guided complete revascularization versus infarct related artery only revascularization in patients with ST-elevation myocardial infarction and multivessel coronary artery disease.
    Neupane S; Singh H; Edla S; Altujjar M; Yamsaki H; Lalonde T; Rosman HS; Eggebrecht H; Mehta RH
    Coron Artery Dis; 2019 Sep; 30(6):393-397. PubMed ID: 31094897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete revascularization reduces cardiovascular death in patients with ST-segment elevation myocardial infarction and multivessel disease: systematic review and meta-analysis of randomized clinical trials.
    Pavasini R; Biscaglia S; Barbato E; Tebaldi M; Dudek D; Escaned J; Casella G; Santarelli A; Guiducci V; Gutierrez-Ibanes E; Di Pasquale G; Politi L; Saglietto A; D'Ascenzo F; Campo G
    Eur Heart J; 2020 Nov; 41(42):4103-4110. PubMed ID: 31891653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Routine invasive strategies versus selective invasive strategies for unstable angina and non-ST elevation myocardial infarction in the stent era.
    Fanning JP; Nyong J; Scott IA; Aroney CN; Walters DL
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD004815. PubMed ID: 27226069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is the optimal approach to a non- culprit stenosis after ST-elevation myocardial infarction - Conservative therapy or upfront revascularization? An updated meta-analysis of randomized trials.
    Anantha Narayanan M; Reddy YN; Sundaram V; Reddy YN; Baskaran J; Agnihotri K; Badheka A; Patel N; Deshmukh A
    Int J Cardiol; 2016 Aug; 216():18-24. PubMed ID: 27135152
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.